risperidone has been researched along with Stammering in 8 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Excerpt | Relevance | Reference |
---|---|---|
"A randomized, double-blind, placebo-controlled study was conducted to assess the efficacy of risperidone in the treatment of developmental stuttering in 16 adults." | 9.09 | Risperidone for the treatment of stuttering. ( Franklin, DL; Gottschalk, LA; Maguire, GA; Riley, GD, 2000) |
"A randomized, double-blind, placebo-controlled study was conducted to assess the efficacy of risperidone in the treatment of developmental stuttering in 16 adults." | 5.09 | Risperidone for the treatment of stuttering. ( Franklin, DL; Gottschalk, LA; Maguire, GA; Riley, GD, 2000) |
"Stuttering is a speech disorder characterised by frequent prolongations, repetitions or blocks of spoken sounds and/or syllables." | 2.42 | Alleviating stuttering with pharmacological interventions. ( Franklin, DL; Maguire, GA; Riley, GD; Yu, BP, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (75.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Sood, S | 1 |
Rocha, FF | 1 |
Tavano, A | 1 |
Busan, P | 1 |
Borelli, M | 1 |
Pelamatti, G | 1 |
Maguire, GA | 2 |
Yu, BP | 1 |
Franklin, DL | 2 |
Riley, GD | 2 |
van Wattum, PJ | 1 |
Ranjan, S | 1 |
Sawhney, V | 1 |
Chandra, PS | 1 |
Gottschalk, LA | 1 |
Lee, HJ | 1 |
Lee, HS | 1 |
Kim, L | 1 |
Lee, MS | 1 |
Suh, KY | 1 |
Kwak, DI | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
An Open-label Study to Evaluate the Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering).[NCT02909088] | Phase 2/Phase 3 | 10 participants (Anticipated) | Interventional | 2016-09-30 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for risperidone and Stammering
Article | Year |
---|---|
Alleviating stuttering with pharmacological interventions.
Topics: Benzodiazepines; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Antagonists; Fronta | 2004 |
1 trial available for risperidone and Stammering
Article | Year |
---|---|
Risperidone for the treatment of stuttering.
Topics: Adult; Aged; Analysis of Variance; Dopamine Antagonists; Double-Blind Method; Female; Humans; Male; | 2000 |
6 other studies available for risperidone and Stammering
Article | Year |
---|---|
A Case Report of Stuttering Induced by Risperidone and Chlorpromazine.
Topics: Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Haloperidol; Humans; Male; Risperidone; Stutt | 2022 |
[Aripiprazole-induced stuttering treated with risperidone].
Topics: Adult; Antipsychotic Agents; Aripiprazole; Female; Humans; Piperazines; Quinolones; Risperidone; Sch | 2009 |
Risperidone reduces tic-like motor behaviors and linguistic dysfluencies in severe persistent developmental stuttering.
Topics: Humans; Language Development Disorders; Linguistics; Male; Risperidone; Severity of Illness Index; S | 2011 |
Stuttering improved with risperidone.
Topics: Antipsychotic Agents; Child, Preschool; Humans; Male; Risperidone; Stuttering | 2006 |
Persistent developmental stuttering: treatment with risperidone.
Topics: Adult; Antipsychotic Agents; Humans; Male; Risperidone; Severity of Illness Index; Stuttering; Treat | 2006 |
A case of risperidone-induced stuttering.
Topics: Adult; Antipsychotic Agents; Humans; Male; Risperidone; Stuttering | 2001 |